Recently, more and more studies indicate that the right diet can prevent the disease and possibly even slow its progression.
Diet and Parkinson's |
|
Recently, more and more studies indicate that the right diet can prevent the disease and possibly even slow its progression.
The so-called Mediterranean cuisine is usually recommended, i.e. lots of fresh greens, lots of vegetables, oils with unsaturated fatty acids, fish, legumes and little meat. More and more studies suggest that this type of diet can also slow down the progression of Parkinson's disease and even reduce the risk of developing it in the first place.
Parkinson's disease begins silently and slowly, many years already lurking in the body before using Tremble or frozen facial expressions become visible. Especially in this phase, a healthy diet is of crucial importance. Experts assume that in this early phase it is still possible to have a particularly positive effect on the disease.
researchers now assume that Parkinson's disease begins with changes in the gut in at least some people. One explanation could be that substances migrate from the intestines into the brain and can have an or harmful effect there. Even if a lot is still unclear, the exchange of messenger substances between the intestine and the brain is considered safe. They can migrate from the intestines to the brain via the blood or nerve tracts. This is known as the gut-brain axis.
So far it is known that the intestines of Parkinson's patients are changed. Many of those affected complain years before the typical symptoms appear about digestive problems such as severe ones constipation.
Studies show that the composition of the microbiome, i.e. the community of intestinal bacteria, is also changed in people with Parkinson's disease. Normally the beneficial inhabitants of the intestines transform us Essen in nutrients, but there are also intestinal bacteria that can make you sick if the balance is disturbed. In people with Parkinson's disease, for example, bacteria often predominate and make the intestinal wall permeable. Substances that promote inflammation can then enter the blood.
-
-
-
-
Healthy diet in Parkinson's disease
Eating and drinking are elementary human needs. Function and performance as well as well-being and joie de vivre are bound to it.
The foundation for this is a healthy diet that is particularly high in fiber. Therefore, include plenty of vegetables, fruit, whole grain products, legumes and potatoes in your daily meals.
A portion of protein goes with every main meal. A good source of protein that covers all requirements is a small portion of lightly prepared meat, sausage or fish per day. The same applies to milk or milk products. Of the 3 servings a day, one serving as a sour milk product such as natural yoghurt or buttermilk supports and protects the function of the intestinal flora.
Vegetable oils such as rapeseed oil, walnut oil, olive oil or linseed oil for the preparation of your meals ensure the supply of essential fatty acids and vitamins.
Stomach and intestines work slower due to illness and medication. Easy and gentle preparation, plenty of fresh herbs, several small portions and a calm, relaxed meal avoid post-meal discomfort and digestive stress.
Chew well and drink plenty of fluids. Food and medicines have to be mixed well in the stomach, dissolved and processed "through the intestines", similar to a washing machine principle. If the food is chewed badly, the portion is too big and too fatty or there is a lack of liquid, this can lead to gastrointestinal problems.
Fatigue, restricted mobility, stomach pressure, feeling of fullness or constipation due to excessively long residence and transport times in the stomach and intestines put a strain on digestion and humans. In addition, the effects of the medication are postponed, changed or lost, since these also reach the blood with a delay.
This plays a very important role when taking levodopa medication. Be sure to take L-Dopa supplements 30 minutes before or 60-90 minutes after a meal to avoid possible fluctuation in effects. In the event of an interaction between dietary protein and L-Dopa, especially in the advanced course of the disease, it helps to plan the majority of protein-containing foods for the evening. Under no circumstances should you do without protein, as this nutrient is essential for life and maintains function. If taking the tablet causes nausea, it can also be taken with a small protein-free/poor snack (applesauce, toast, bread, rusk, savory biscuits, jelly or similar).
One of the most common changes and complications in all phases of the disease is the swallowing disorder. This can be silent, with no visible or noticeable signs, and can vary in severity at different times of the day. In the case of a swallowing disorder, changing the consistency of food or thickening drinks may be necessary to avoid serious complications. Here, the logopedic recommendations should be followed.
If you notice an unwanted weight loss, the intake of food energy is insufficient. You can enrich the usual food or use additional food supplements. This requires prior consultation with your doctor and a dietitian.
Dry mouth can be caused by the condition and medications, and it makes eating and swallowing difficult. Sip suitable beverages throughout the day, such as still water with a little lemon, light teas. Smearing the inside of the mouth with a little oil (e.g. lemon oil) can provide relief in between, as can rinsing out the mouth after eating with e.g. B. pineapple juice or sucking ice cubes from pineapple juice, even diluted, can be helpful. Sugary drinks, confectionery or chewing gum with menthol or peppermint, on the other hand, are unsuitable. Suitable chewing gums that stimulate salivation are available in pharmacies.
If you have too much saliva, practice swallowing the saliva. Chamomile, peppermint and sage tea have a supporting effect, as do menthol and peppermint sweets.
If you have a swallowing disorder or if there is an increased risk of swallowing, discuss these measures in advance with your speech therapist/doctor.
In brief:
Source: Jeannette Obereisenbuchner
DA/Med.EB/diabetes consultant DDG
published at https://www.parkinson-beelitz.de/parkinson-infos/ernaehrung.html
Peculiarities of nutrition with Parkinson's disease
Already in 2012 the nutritionist Angelika Raff described it the site "www.parkinson-web.de“, (a cooperation of the Gertrudis-Klinik Biskirchen and the German Parkinson Association eV) in great detail what you should or even have to pay attention to as a Parkinson’s patient.
It is once again one of those issues that you have to take care of yourself. Neither during my numerous visits to the doctor nor during the clinic and rehabilitation stays was the topic of nutrition given the necessary importance. Even the well-intentioned lectures during my complex therapy were nothing more than a collection of Power Point slides with the quintessence: “Eat healthily”. My mother always told us children that, as true as the statement is, it is not very helpful as a recommendation for action. Fortunately, there are now more and more nutritionists who specialize in neurodegenerative diseases. For example, the Google query “Nutritional advice and Parkinson’s” yields the following result: Google hit list .
But be careful: Not every offer is serious and caution is advised, especially when food supplements are advertised. Promises of salvation are easy to make and we are all too happy to believe in the one remedy that will make us happy.
But read for yourself...
Although some countries even produce canned foods for Parkinson's patients, we must start by saying that there is no specific diet for Parkinson's disease. Based on current knowledge, it is also not possible to stop the progression of the disease with a specific diet. Nevertheless, care should be taken to ensure a varied diet in order to ensure an adequate supply of nutrients.
However, there are some peculiarities of the diet of Parkinson's patients, which will be discussed below.
A significant problem is the interaction (interaction between two or more drugs in the sense of a quantitative [weakening or strengthening] or qualitative change in the effect of simultaneous or sequential drug administration) between L-Dopa-containing drugs and the protein intake.
Parkinson's patients treated with L-Dopa can develop an interaction with protein-containing food in the advanced stages of the disease, ie after the occurrence of fluctuations in the effect. Because of this fact, protein restriction with simultaneous L-Dopa treatment came up for discussion. However, we must emphasize that a low-protein diet is not necessary or even harmful.
The interaction between L-Dopa and protein intake is based on the following facts:
To avoid this interaction, it is recommended that the L-Dopa dose be taken 1,5 hour before or XNUMX hours after food intake.
There are a few exceptions to this recommendation:
There are some patients who have severe akinesia (off phase) after the main meal in the early afternoon. These patients should try to keep their meals low in protein during the day and get all the protein they need at dinner.
It is also known that carbohydrates (carbohydrates [carbohydrates, saccharides] a collective term for a widespread group of natural substances, which includes all types of sugar, starch and cellulose) play a role in the absorption of L-Dopa, they can affect the L - Promote dopa uptake in the brain. The increased administration of carbohydrates is particularly recommended if the patient has lost weight (eg if severe hyperkinesia occurs). However, a high-carbohydrate and low-protein diet can lead to an increase in hyperkinesia (pathologically increased motor activity, especially in the skeletal muscles with sometimes involuntary movements).
Gastric emptying plays an important role in the effectiveness of L-Dopa. The longer L-Dopa stays in the stomach, the less L-Dopa is available for absorption in the small intestine. Numerous factors influence the rate of gastric emptying; e.g. B. Increased gastric acid production has a slowing effect. Medications such as anticholinergics can also slow down gastric emptying.
Corresponding drugs against gastric acid and drugs that accelerate gastric emptying - such as domperidone - can significantly increase the effect of L-Dopa.
Studies have shown that L-Dopa works fastest when taken on an empty stomach. Dissolvable L-Dopa preparations can significantly accelerate this effect. The dissolved L-Dopa tablet can be helpful for early-morning akinesia (delayed starting) and resorption disorders and swallowing disorders, but also for protein akinesia.
Another important group of drugs are the dopamine agonists, which compensate for the lack of dopamine in Parkinson's disease in a different way than L-dopa preparations. Their effect is usually not affected by meals or a high-protein diet.
The trembling, the permanent tension of the muscles and the effort to complete a movement that has been started as well as the L-Dopa-triggered over-movements cost a lot of energy. Medications often cause nausea and vomiting. The result is weight loss. To influence these problems, there are some recommendations regarding food intake:
The disease-related constipation, the lack of exercise, the insufficient fluid intake and the side effects of the medication in Parkinson's disease cause chronic constipation.
Suitable countermeasures are:
In advanced cases of Parkinson's disease, the swallowing process is also made more difficult. In addition, chewing is also impaired. As a result, in such cases, care must be taken to eat a bite-sized diet. Particularly recommended are:
Wood and chips | potatoes |
---|---|
toast Brown bread without crust soft-boiled noodles semolina melting flakes rice pudding shortbread ladyfingers |
Salt potatoes Mashed Potatoes |
Vegetables | fruit raw |
cauliflower Broccoli Cucumbers without skin and seeds kohlrabi carrots Brussels sprouts Beetroot salsify Celery spinach tomato flesh zucchini |
Avocado pear nectarine Peach without skin |
Milk, dairy products, cheese, eggs | meat, sausage |
milk milkshakes buttermilk Kefir yogurt Quark all types of cheese except processed cheese freshly prepared scrambled eggs |
Poultry fine bratwurst hot dog fricassee Fleischwurst pie Tea sausage Liverwurst |
Fish | Herbs & Spices |
plaice fillet Boiled fish with soft flesh |
sweet and sour salty |
Drinks | Desserts |
fruit juices vegetable juices fruit juices (thickened) milk milkshakes |
Creams jelly smooth pudding groats Ice Cream |
Some general ground rules to keep in mind:
neuroprotection
One of the most important goals of research is to slow down and even stop the progressive degeneration. These efforts are summarized under the term "neuroprotection" (= protection of the nerve cells).
In a broader sense, these neuroprotective research approaches have the following objectives:
For the affected patients, slowing down or halting cell atrophy and thus promoting the course of the disease is of the greatest importance. If the state of the black matter could be preserved at an early stage of diagnosis, i.e. when the first symptoms appear or when the first suspicions arise, further deterioration of the disease would in all probability be avoidable. But even a significant slowdown in the progression of the disease would delay the late complications significantly.
In risk groups, e.g. relatives of Parkinson's patients with several affected people in the family, people with loss of the sense of smell or if other tests indicate a risk, early neuroprotective treatment could be given Therapy prevent the outbreak of the disease.
With regard to the neuroprotective effect of L-Dopa, the clinical data are sometimes contradictory. In the double-blind, randomized ELLDOPA study, a better clinical condition compared to the placebo group could be demonstrated in the L-Dopa group even after discontinuation of L-Dopa. However, the imaging method DATScan showed a higher density of dopamine transporters in the placebo group, i.e. a slower progression. Accordingly, the question of the effect of L-Dopa on the course of the disease remains unclear.
The dopamine agonists, which were previously used in the late stages of the disease, have also been used in early therapy and in younger (under 90 years) patients as initial medication since the 70s. They are theoretically neuroprotective, reduce the dopamine metabolism in the diseased cells and thereby relieve them. Accordingly, the production of free radicals is also suppressed. In animal experiments, dopamine agonists also have a so-called antioxidant effect, i.e. they can neutralize harmful free radicals.
In the REAL-PET study, the progressive cell atrophy in the black matter between L-Dopa and ropinirole was compared using fluoro-dopa PET. At the PET follow-up after several years, fluorodopa uptake in the striated brain was significantly higher in the ropinirole group. The ropinirole group thus showed a slowdown in cell wasting. The CALM-PD study tested pramipexole versus L-Dopa for the effect on cell wasting using the DATScan study. The patients treated with pramipexole from the start showed a higher density of dopamine transporters at the end of the study.
The PELMOPET study with pergolide showed similar results.
These study results were interpreted in such a way that treatment with the said dopamine agonists could slow down cell atrophy in the black matter. At the same time, however, doubts were raised as to whether the Fluoro-Dopa-PET and the DATScan examinations are suitable for measuring the number of nerve cells that are still left in the black matter.
Numerous clinical experiences spoke for a beneficial effect of the MAO-B inhibitor selegiline on the course of the disease. In the DATATOP study, selegiline was compared to vitamin E and placebo. The beneficial effect of selegiline was initially assessed as slowing down the progression of the disease, later this effect was classified as only symptomatic. Subsequent studies with so-called washout phases proved that selegiline has a slight neuroprotective effect, at least in the first years of the disease. Vitamin E showed the same effectiveness as placebo.
The new MAO-B inhibitor rasagiline was investigated in the TEMPO study, this study also suggests a slight slowdown in disease progression. The ADAGIO study with rasagiline seems to confirm the slight neuroprotective effect at a dosage of 1 mg/day. However, the lack of effect at the higher dosage (2 mg/day) raises doubts about this assessment.
Based on laboratory and animal experiments, a slight effect of the amantadine preparations, which favors the course, is to be expected
In the already mentioned DATATOP study, no effect of vitamin E on the course of Parkinson's disease could be determined. In smaller, uncontrolled studies, the specific treatment of Parkinson's disease could be postponed by up to 2 years through the high-dose administration of vitamins E and C. These results could not be confirmed in a larger, placebo-controlled study.
According to some studies, the level of this antioxidant, which is active in the energy centers of the cells, is reduced in the brains of Parkinson's patients. Q10 is also a so-called radical scavenger in the test tube. One study found a minimal protective effect, although it was not clear if the effect was only symptomatic. A controlled study found no difference between placebo and Q10. The German study could not prove any effect on the symptoms.
Creatine is a dietary supplement that is also used by athletes to improve performance. A neuroprotective effect was found in animal experiments, but its effectiveness has not yet been confirmed in humans.
In animal experiments, the active ingredient in green tea has an antioxidant effect. So far, no neuroprotective effect has been confirmed in humans.Caffeine
Epidemiological studies suggest that the risk of developing Parkinson's disease is lower in people who consume higher amounts of coffee or tea. Animal experiments showed a slight neuroprotective effect. Caffeine is an adenosine receptor antagonist.
The neuroprotective effectiveness of nicotine has been discussed on the basis of epidemiological studies that demonstrate the increased frequency of Parkinson's disease in non-smokers. Because of the negative effects, however, nicotine is not a treatment alternative.
The neuroprotective effectiveness of iron chelators, estrogens, ghrelin gastric hormone, minocycline cholesterol lowering agents, Ca antagonists, aspirin, COX-2 inhibitors is also under discussion.
In addition to the possibilities mentioned above for positively influencing the natural course of the disease, there are numerous substances that show neuroprotective effects in the test tube or in animal experiments. An important research task is to find those substances from these substances that are also effective and harmless in humans. Almost every month we can read something new about the growing possibilities of neuroprotection. However, it is a long way before a new idea or a new substance can be used successfully in therapy.
Unfortunately, our previous neuroprotective options are still very limited. The protective effectiveness of the means that are available is minimal. Irrespective of this, today's knowledge of neuroprotection should also be incorporated into the strategy of Parkinson's therapy.
Nevertheless, we can hope that in the foreseeable future it will be possible not only to treat the disease symptomatically, but also to promote its course or even stop the disease process.
Based on the theory of oxidative stress in the development of Parkinson's disease, antioxidants could have a neuroprotective effect, ie slow down the death of the nigra cells. We know that when the first symptoms of Parkinson's appear, around 50 percent of the nigra cells are no longer functioning and that further death ultimately means that these nerve cells are missing. The antioxidants could therefore only work in the initial phase of the disease by slowing down the progression and not bring about a spectacular improvement in the symptoms, as should have been the case in television reports about the significant improvement of the late Pope, John Paul II, with papaya extracts.
From the group of antioxidants (radical scavengers), vitamin E was tested most frequently. In the well-controlled DATATOP study, no effect on the symptoms or the progression of the disease could be demonstrated, even with high doses (doses of up to 2000 units/day). Higher doses can cause significant side effects (hypervitaminosis).
Based on theoretical considerations, an intake of two to three grams/day was recommended. The effect on disease progression or on symptoms has not been proven.
This dietary supplement is neuroprotective in preclinical animal models of Parkinson's disease through its effects on mitochondrial function (energy centers of nerve cells), which of course does not mean that Q10 has the same effect in humans. The previous data from uncontrolled studies are contradictory, low doses were definitely ineffective, higher ones questionable. The controlled study of the German Parkinson Association, which was carried out under the leadership of the University Hospital Dresden, could not prove the effectiveness on the symptoms. In an American, uncontrolled study, the effect on disease progression was not convincing.
The French virologist Montagnier (discoverer of the AIDS virus) recommended giving papaya extracts as antioxidants to Parkinson's patients, including the late Pope John Paul II. This was followed by numerous newspaper and television reports that attributed the Pope's visible improvement in condition to the papaya gift. According to information from Prof. Gianni Pezzoli on the website of the Italian Parkinson Society, the improvement of the Holy Father was due to a levodopa administration.
Green tea is currently in the focus of alternative medicine as a radical scavenger and thus an anti-aging and anti-cancer agent. A neuroprotective effect could also be detected in cell cultures and in rats, which is probably due to the antioxidant effect. Larger studies in humans and in Parkinson's patients are not yet known.
Source: December 2012 | dr Ferenc Fornadi, Gertrudis Clinic Biskirchen
Food protects nerve cells
Studies show that certain foods can protect nerve cells.
Are good:
|
Bad are:
|
Those who do not want to do without meat should at least rely on white meat, i.e. poultry instead of beef or pork.
dietary supplements
Interactions of diet and medication
But not only what you eat is important. Timing is also important because some Parkinson's medications must not be taken with certain foods. Anyone who takes the standard drug for Parkinson's disease, L-Dopa, must not do so together with protein-containing food, because then the drug has a worse effect. Therefore, those affected should always take a break before and after taking the tablets.
A study is currently examining whether the intestinal microbiome can be normalized by so-called intermittent fasting. For a week, the participants only eat vegetable broth, after which they take long breaks between meals for a year. Many participants report temporary relief from symptoms and a better quality of life. The final result of the study is still pending.